Survey on Treatment Adherence with the Easypod™ Auto-Injector in Children
Author Information
Author(s): Bozzola Mauro, Colle Michel, Halldin-Stenlid Maria, Larroque Sylvain, Zignani Monia
Primary Institution: Paediatric Department, University of Pavia, IRCCS San Matteo Foundation, Pavia, Italy
Hypothesis
Does the easypod™ auto-injector improve adherence to r-hGH treatment in children?
Conclusion
The easypod™ auto-injector shows good adherence to r-hGH treatment among children, especially those new to treatment.
Supporting Evidence
- 87.5% of children were adherent to treatment over the 3-month period.
- Recorded adherence was higher in treatment-naïve children (89.7%) than in treatment-experienced children (81.7%).
- Over 90% of children/parents wanted to continue using the easypod™.
Takeaway
Most kids using the easypod™ for their growth hormone shots remembered to take their medicine, and they liked using the device.
Methodology
A multicentre, multinational, observational survey over 3 months where children used the easypod™ and reported their adherence.
Potential Biases
Potential bias in self-reported adherence data compared to recorded data.
Limitations
The study only followed participants for 3 months and relied on self-reported data for some adherence measures.
Participant Demographics
Children aged 1-18 years, with 56.1% boys and a mix of treatment-naïve and treatment-experienced participants.
Statistical Information
P-Value
0.0062
Statistical Significance
p = 0.0062
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website